Stockscreener 앱 받기
7.35
0.55%
0.04
전일 마감가:
$7.31
열려 있는:
$7.31
하루 거래량:
746.42K
Relative Volume:
0.46
시가총액:
$705.73M
수익:
-
순이익/손실:
$-144.32M
주가수익비율:
-3.3716
EPS:
-2.18
순현금흐름:
$-105.21M
1주 성능:
+1.80%
1개월 성능:
+15.02%
6개월 성능:
+87.02%
1년 성능:
+115.54%
1일 변동 폭
$7.07
$7.4608
1주일 범위
$6.82
$7.75
52주 변동 폭
$2.25
$8.20
Compass Pathways Plc Adr Stock (CMPS) Company Profile
명칭
Compass Pathways Plc Adr
전화
1-716-676-6461
주소
3RD FLOOR, 1 ASHLEY ROAD, CHESIRE
CMPS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CMPS
Compass Pathways Plc Adr
|
7.35 | 701.88M | 0 | -144.32M | -105.21M | -2.18 |
|
HCA
Hca Healthcare Inc
|
469.29 | 110.40B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
196.74 | 17.69B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
21.95 | 12.54B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
199.88 | 12.76B | 16.08B | 1.20B | 1.06B | 17.82 |
|
ENSG
Ensign Group Inc
|
180.57 | 10.63B | 4.11B | 239.98M | 193.10M | 4.12 |
Compass Pathways Plc Adr Stock (CMPS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-10 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-06-23 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2025-02-27 | 개시 | Stifel | Buy |
| 2024-07-23 | 개시 | RBC Capital Mkts | Outperform |
| 2024-04-01 | 개시 | Morgan Stanley | Overweight |
| 2023-12-12 | 개시 | Deutsche Bank | Buy |
| 2022-11-21 | 재개 | Berenberg | Buy |
| 2022-11-01 | 개시 | Loop Capital | Buy |
| 2021-10-29 | 개시 | Oppenheimer | Outperform |
| 2021-07-13 | 개시 | Citigroup | Buy |
| 2021-06-28 | 개시 | Maxim Group | Buy |
| 2021-05-11 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-04-01 | 개시 | ROTH Capital | Buy |
| 2020-10-14 | 개시 | H.C. Wainwright | Buy |
| 2020-10-13 | 개시 | Berenberg | Buy |
| 2020-10-13 | 개시 | Canaccord Genuity | Buy |
| 2020-10-13 | 개시 | Cowen | Outperform |
| 2020-10-13 | 개시 | Evercore ISI | Outperform |
모두보기
Compass Pathways Plc Adr 주식(CMPS)의 최신 뉴스
COMPASS Pathways (NASDAQ:CMPS) Trading Down 5.5%What's Next? - MarketBeat
CMPS: COMP360 is poised to transform TRD and PTSD care with rapid, durable efficacy and broad support - TradingView — Track All Markets
CMPS: COMP360 is set to transform psychiatric care for PTSD and TRD with rapid, durable outcomes - TradingView — Track All Markets
COMPASS Pathways (NASDAQ:CMPS) Sets New 1-Year HighShould You Buy? - MarketBeat
CMPS: COMP360 demonstrates rapid, durable efficacy in TRD and PTSD, supporting near-term commercialization - TradingView — Track All Markets
Compass Pathways stock rises after FDA accepts IND for PTSD treatment By Investing.com - Investing.com South Africa
Compass Pathways stock rises after FDA accepts IND for PTSD treatment - Investing.com
Compass Pathways (Nasdaq:CMPS) Enters Strategic Collaboration with Radial Health - Kalkine Media
Compass Pathways forms seventh strategic collaboration with Radial Health By Investing.com - Investing.com India
Compass Pathways forms seventh strategic collaboration with Radial Health - Investing.com
COMPASS Pathways (CMPS) Upgraded to Buy: Here's What You Should Know - sharewise.com
Simplify Asset Management Inc. Purchases Shares of 290,000 COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Why COMPASS Pathways plc (CMPS) Draws Both Optimism and Caution - Finviz
COMPASS Pathways (NASDAQ:CMPS) Trading 4.5% HigherStill a Buy? - MarketBeat
Analyzing COMPASS Pathways (NASDAQ:CMPS) & HealthEquity (NASDAQ:HQY) - Defense World
COMPASS Pathways (NASDAQ:CMPS) Reaches New 12-Month HighShould You Buy? - MarketBeat
COMPASS Pathways (NASDAQ:CMPS) Shares Gap UpWhat's Next? - MarketBeat
Healthy Upside Potential: Compass Pathways Plc ADR (CMPS) - setenews.com
Oppenheimer upgrades Compass Pathways stock to Outperform on FDA pathway By Investing.com - Investing.com UK
COMPASS Pathways PLC Sponsored ADR $CMPS Position Boosted by 22NW LP - MarketBeat
Schroder Investment Management Group Makes New $1.53 Million Investment in COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
1,075,485 Shares in COMPASS Pathways PLC Sponsored ADR $CMPS Purchased by Hsbc Holdings PLC - MarketBeat
COMPASS Pathways (NASDAQ:CMPS) Trading 10.7% HigherWhat's Next? - MarketBeat
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Prepare Yourself for Liftoff: Compass Pathways Plc ADR (CMPS) - Setenews
Compass Pathways Stock: Navigating Volatility in Psychedelic Medicine () - aktiencheck.de
Ready to Jump After Recent Trade: Triller Group Inc (ILLR) - Setenews
Investors in cash trouble should check out Compass Pathways Plc ADR (CMPS) - Setenews
Bridger Management LLC Purchases New Holdings in COMPASS Pathways PLC Sponsored ADR $CMPS - Defense World
Discontinued operations of COMPASS Pathways Plc Sponsored ADR – HAM:5Y6 - TradingView
COMPASS Pathways Plc Sponsored ADR Trade Ideas — HAM:5Y6 - TradingView
The time has not yet come to remove your chips from the table: Compass Pathways Plc ADR (CMPS) - Setenews
Free cash flow per share of COMPASS Pathways Plc Sponsored ADR – LS:A2QCDR - TradingView
This trade activity should not be overlooked: Compass Pathways Plc ADR (CMPS) - Setenews
Compass Pathways Announces Third Quarter 2025 Financial Results and Business Highlights Including Acceleration of Commercial Launch Plans by 9-12 Months - Placera.se
Sumitomo Mitsui Trust Group Inc. Has $615,000 Stock Holdings in COMPASS Pathways PLC Sponsored ADR $CMPS - Defense World
NeuroKaire Enters into R&D Collaboration with Compass Pathways to Pioneer Precision Treatments for Depression - Barchart.com
Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors - ANSA
Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025 - Barchart.com
ARK Investment Management LLC Sells 155,582 Shares of COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
Compass Pathways soars 62% after December Fair Value signal - Investing.com
Compass Pathways: Maintain Hold Rating With COMP360 Going Beyond TRD Development (CMPS) - Seeking Alpha
COMPASS Pathways (NASDAQ:CMPS) Reaches New 52-Week High After Analyst Upgrade - Defense World
COMPASS Pathways (NASDAQ:CMPS) Price Target Raised to $14.00 at BTIG Research - Defense World
COMPASS Pathways (NASDAQ:CMPS) Sets New 52-Week High After Analyst Upgrade - MarketBeat
Compass Pathways Plc ADR (CMPS) expanding its growth trajectory ahead - Setenews
COMPASS Pathways (NASDAQ:CMPS) Sets New 12-Month HighWhat's Next? - MarketBeat
Goldman Sachs Group Inc. Sells 81,540 Shares of COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
COMPASS Pathways (NASDAQ:CMPS) Trading 6.4% HigherShould You Buy? - MarketBeat
Compass Pathways Plc Adr (CMPS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.22%
자본화:
|
볼륨(24시간):